Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

PIKFyve is essential for normal platelet function and its deficiency causes organ issues and macrophage infiltration.

Abrocitinib may effectively treat stubborn alopecia universalis.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

The combination treatment showed a higher response rate but no significant survival benefits.

Tofacitinib may effectively treat folliculitis decalvans.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

ATP helps prevent skin damage from vandetanib by reducing stress.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.